Trademark: 97176339
Word
TALRAMZY
Status Date
Wednesday, November 29, 2023
Filing Date
Thursday, December 16, 2021
Published for Opposition
Tuesday, November 1, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Dec 20, 2021
New Application Entered
Dec 21, 2021
New Application Office Supplied Data Entered
Sep 22, 2022
Assigned To Examiner
Sep 26, 2022
Approved For Pub - Principal Register
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Nov 1, 2022
Published For Opposition
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 13, 2023
Assigned To Examiner
May 25, 2023
Sou Teas Extension Received
May 25, 2023
Sou Extension 1 Filed
May 25, 2023
Sou Extension 1 Granted
May 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Teas Extension Received
Nov 29, 2023
Sou Extension 2 Filed
Nov 29, 2023
Sou Extension 2 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
May 24, 2024
Sou Teas Extension Received
Trademark Alertz updated from USPTO on 2030-01-24
